Literature DB >> 7824166

Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia.

H Tohgi1, T Abe, K Hashiguchi, M Saheki, S Takahashi.   

Abstract

We determined the concentrations of acetylcholine (ACh) and choline (Ch) in the cerebrospinal fluid (CSF) of patients with Alzheimer type dementia (ATD) in comparison with controls. The ACh concentration was reduced significantly and remarkably (73%, P < 0.0002) in ATD patients and had a significant positive correlation with dementia scale scores (r = 0.82, P < 0.05). The Ch concentration was unaltered in ATD patients. These results suggest that the progressive reduction in ACh in the ATD brain may be reflected in its concentrations in the CSF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824166     DOI: 10.1016/0304-3940(94)90064-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

Authors:  Romina M Uranga; Annadora J Bruce-Keller; Christopher D Morrison; Sun Ok Fernandez-Kim; Philip J Ebenezer; Le Zhang; Kalavathi Dasuri; Jeffrey N Keller
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

2.  The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease.

Authors:  G Ehrenstein; Z Galdzicki; G D Lange
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

3.  Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

Authors:  H Tohgi; T Abe; M Kimura; M Saheki; S Takahashi
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 4.  The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer's Disease.

Authors:  Avinash Shenoy; Meheli Banerjee; Archana Upadhya; Siddhi Bagwe-Parab; Ginpreet Kaur
Journal:  Front Behav Neurosci       Date:  2022-06-13       Impact factor: 3.617

Review 5.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers.

Authors:  Shaun M Frost; Yogesan Kanagasingam; Hamid R Sohrabi; Kevin Taddei; Randall Bateman; John Morris; Tammie Benzinger; Alison Goate; Colin L Masters; Ralph N Martins
Journal:  Curr Alzheimer Res       Date:  2013-10       Impact factor: 3.498

7.  Bridging molecular genetics and biomarkers in lewy body and related disorders.

Authors:  Gilbert J Ho; Willie Liang; Masaaki Waragai; Kazunari Sekiyama; Eliezer Masliah; Makoto Hashimoto
Journal:  Int J Alzheimers Dis       Date:  2011-07-03

8.  Metabolite profiling of Alzheimer's disease cerebrospinal fluid.

Authors:  Christian Czech; Peter Berndt; Kristina Busch; Oliver Schmitz; Jan Wiemer; Veronique Most; Harald Hampel; Jürgen Kastler; Hans Senn
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

9.  Cholinergic Enhancement of Cell Proliferation in the Postnatal Neurogenic Niche of the Mammalian Spinal Cord.

Authors:  Laura F Corns; Lucy Atkinson; Jill Daniel; Ian J Edwards; Lauryn New; Jim Deuchars; Susan A Deuchars
Journal:  Stem Cells       Date:  2015-06-26       Impact factor: 6.277

Review 10.  Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.

Authors:  Roni Manyevitch; Matthew Protas; Sean Scarpiello; Marisa Deliso; Brittany Bass; Anthony Nanajian; Matthew Chang; Stefani M Thompson; Neil Khoury; Rachel Gonnella; Margit Trotz; D Blaine Moore; Emily Harms; George Perry; Lucy Clunes; Angelica Ortiz; Jan O Friedrich; Ian V J Murray
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.